(Q34637919)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18565882%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Phase II trial of docetaxel with rapid androgen cycling for progressive noncastrate prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18565882%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

main subject

phase II clinical trial

0 references

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18565882%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18565882%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18565882%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Howard I Scher

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18565882%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Susan F Slovin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18565882%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Michael A Carducci

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18565882%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Mario A Eisenberger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18565882%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Roberto Pili

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18565882%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Samuel R Denmeade

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18565882%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Moshe Kelsen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18565882%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Tracy Curley

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18565882%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Melinda Halter

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18565882%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Connie Collins

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18565882%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Martin Fleisher

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18565882%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Glenn Heller

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18565882%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

English

0 references

publication date

1 June 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18565882%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Oncology

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18565882%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18565882%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18565882%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

2959-2965

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18565882%20AND%20SRC:MED&resulttype=core&format=json

Mitogenic action of the androgen receptor sensitizes prostate cancer cells to taxane-based cytotoxic insult

9 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051836

Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051836

Phase II evaluation of docetaxel plus exisulind in patients with androgen independent prostate carcinoma.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051836

Neoadjuvant docetaxel before radical prostatectomy in patients with high-risk localized prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051836

Effect of docetaxel in patients with hormone-dependent prostate-specific antigen progression after local therapy for prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051836

Evidence for a p27 tumor suppressive function independent of its role regulating cell proliferation in the prostate

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051836

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051836

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051836

Cell proliferation and apoptosis in prostate tumors and adjacent non-malignant prostate tissue in patients at different time-points after castration treatment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051836

Mitoxantrone in patients with prostate specific antigen progression after local therapy for prostate carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051836

Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051836

Docetaxel followed by hormone therapy in men experiencing increasing prostate-specific antigen after primary local treatments for prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051836

Factors affecting cytochrome P-450 3A activity in cancer patients.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051836

Phase II trial of estramustine and etoposide in androgen-sensitive metastatic prostate carcinoma

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051836

Simultaneous analysis of docetaxel and the formulation vehicle polysorbate 80 in human plasma by liquid chromatography/tandem mass spectrometry

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051836

Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051836

Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051836

Phase II Evaluation of Oral Estramustine, Oral Etoposide, and Intravenous Paclitaxel in Patients with Hormone-Sensitive Prostate Adenocarcinoma

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051836

Prostate-specific antigen nadir and cancer-specific mortality following hormonal therapy for prostate-specific antigen failure

9 December 2018

1 reference

12 December 2020

Androgen deprivation for minimal metastatic disease: threshold for achieving undetectable prostate-specific antigen

1 reference

12 December 2020

Prostate cancer cell cycle regulators: response to androgen withdrawal and development of androgen independence

1 reference

12 December 2020

Clinical states in prostate cancer: toward a dynamic model of disease progression

1 reference

12 December 2020

Adjuvant mitozantrone chemotherapy in advanced prostate cancer

1 reference

12 December 2020

Rapid androgen cycling as treatment for patients with prostate cancer.

1 reference

12 December 2020

Docetaxel, estramustine, and 15-month androgen deprivation for men with prostate-specific antigen progression after definitive local therapy for prostate cancer

1 reference

12 December 2020

Identifiers

DOI

10.1200/JCO.2007.15.1928

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18565882%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18565882%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

PubMed publication ID

18565882

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18565882%20AND%20SRC:MED&resulttype=core&format=json